Trulicity 1.5 mg: the second step and the pediatric maximum
The short answer
Trulicity 1.5 mg once weekly is the second step on the FDA label. The dose may go up to it after 4 weeks on 0.75 mg for more blood sugar control, and it's the maximum for pediatric patients. Adults may go on to 3 mg after at least 4 weeks. A carton of four pens starts at $389 a month self-pay.
Key takeaways
- Trulicity 1.5 mg can start after 4 weeks on 0.75 mg, if more blood sugar control is needed.
- It's the maximum dose for pediatric patients 10 years and older. Only adults go higher.
- With a sulfonylurea or insulin, the label tells prescribers to consider lowering that dose, to reduce low blood sugar risk.
- A dose change means a new prescription. Ask your pharmacist what to do with leftover 0.75 mg pens.
- LillyDirect self-pay starts at $389 a month, the same at every strength.
What the label says about Trulicity 1.5 mg
Once weeklyA labelled maintenance doseAt least 28 days before any increase
Escalate further only if additional glycemic control is needed.
After 4 weeks, the dosage may be increased to 1.5 mg once weekly for additional glycemic control. If additional glycemic control is needed, increase the dosage in 1.5 mg increments after at least 4 weeks on the current dosage.
Comes as: Single-dose pen.
FDA label: Revised: 3/2026 (DailyMed version 62)
Trulicity dose schedule from the label
TrulicityRevised: 3/2026 (DailyMed version 62)
- 10.75 mg28 daysMaintenance dose
- 21.5 mg28 daysThis page
- 33 mg28 daysMaintenance dose
- 44.5 mg28 daysMaintenance dose
Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.
Supply per fill
| Form | Doses per device | Doses per fill | Days per fill | Fills per year |
|---|---|---|---|---|
| Single-dose pen | 1 | 4 | 28 | 13 |
Track run-out and refill dates with the supply tracker.
Trulicity 1.5 mg: every way to pay, cheapest first
This table uses the 1.5 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.
| How you pay | Form | Per fill | Cost per mg | Conditions | Source |
|---|---|---|---|---|---|
| LillyDirect self-pay | Single-dose pen | $389 | $64.83 | ConditionsSelf-pay only through LillyDirect; the same $389/month starting price is shown for every strength (0.75, 1.5, 3 and 4.5 mg). Prescription required; additional taxes and fees may apply; purchase terms apply. | lilly.com |
Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.
If you miss a dose of Trulicity
You can move your weekly day, as long as your last dose was at least 3 days before the new day.
The day of weekly administration can be changed, if necessary, as long as the last dose was administered 3 or more days before the new day of administration.
If your next dose is still 3 or more days away, take the missed dose now and keep your usual weekly day.
If a dose is missed, instruct patients to administer the dose as soon as possible if there are at least 3 days (72 hours) until the next scheduled dose.
If your next dose is due in 1 or 2 days, skip the missed one and take the next dose on your usual day.
If less than 3 days remain before the next scheduled dose, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
Enter your own dates in the missed-dose helper. If you are unsure, call your prescriber or pharmacist; never take two doses to catch up.
More of the Trulicity label is written about 1.5 mg than about any other strength. It’s the first step up from the 0.75 mg starting dose, the dose used in the label’s cardiovascular outcomes trial, and the highest dose a pediatric patient can be given.
Where 1.5 mg sits
The label gives it two neighbors:
- From below: “After 4 weeks, the dosage may be increased to 1.5 mg once weekly for additional glycemic control.”
- To above: “If additional glycemic control is needed, increase the dosage in 1.5 mg increments after at least 4 weeks on the current dosage.” The next strength is 3 mg.
Glycemic control means blood sugar control. For pediatric patients (Trulicity is approved for type 2 diabetes from 10 years of age), 1.5 mg is the maximum. Only adults continue to 3 mg and 4.5 mg. The titration schedule tool dates each step.
What the label reports at 1.5 mg
Blood sugar and weight. HbA1c is a blood test that measures average blood sugar. Added to metformin, HbA1c change at 26 weeks was -1.2% on 1.5 mg, against 0.1% on placebo (an inactive treatment). Average weight reduction in that trial was 3.0 kg on 1.5 mg and 1.4 kg on placebo.
Cardiovascular outcomes. The REWIND trial followed people for a median of 5.4 years. Trulicity 1.5 mg reduced the risk of the combined endpoint, a single measure of cardiovascular death, non-fatal heart attack or non-fatal stroke, with a hazard ratio of 0.88 against placebo. A hazard ratio compares risk between groups.
Low blood sugar with a sulfonylurea. In a 78-week trial, hypoglycemia (low blood sugar) with glucose below 54 mg/dL occurred in 21% of people taking Trulicity 1.5 mg together with a sulfonylurea. This is why the label tells prescribers to consider reducing a sulfonylurea or insulin dose.
Stomach side effects. Nausea was reported by 21.1% of people on 1.5 mg, vomiting by 12.7% and diarrhea by 12.6%. On placebo the figures were 5.3%, 2.3% and 6.7%.
Price: the same carton price as 0.75 mg
Moving up to 1.5 mg doesn’t change what you pay on the self-pay route. LillyDirect starts at $389 a month for every strength, and the list price is $1,006.93 a month.
If you stay at 1.5 mg, a year of 13 cartons at the self-pay price is $5,057. With insurance, your plan sets the cost, so see the Trulicity cost page.
Supply and form
A carton is four single-dose 1.5 mg pens for 28 days. Each strength is a separate carton and a separate prescription, so a dose change means a new prescription from your prescriber. If you have 0.75 mg pens left when your dose changes, ask your pharmacist what to do with them. The label doesn’t describe combining pens to make a larger dose.
The pen is the only form of Trulicity. The Trulicity guide explains how to use and store it, and the dosing hub compares schedules across medicines.
Where to get Trulicity
1. LillyDirect self-pay
$389 per fill at 1.5 mg
Source: lilly.comGo to the program page
Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.
Frequently asked questions
When do you go from Trulicity 0.75 mg to 1.5 mg?
The label says that after 4 weeks on 0.75 mg, the dosage may go up to 1.5 mg once weekly for additional glycemic control. So the earliest switch is with your fifth weekly injection, after one carton of 0.75 mg pens. The increase happens if you need more blood sugar control, and your prescriber decides.
Is 1.5 mg the highest dose of Trulicity?
For pediatric patients, yes: the maximum for patients 10 years and older is 1.5 mg once weekly. For adults, no. If additional glycemic control is needed, the label allows increases in 1.5 mg steps after at least 4 weeks on the current dose, to 3 mg and then to the adult maximum of 4.5 mg.
What did the heart outcomes trial show for Trulicity 1.5 mg?
In the REWIND trial described on the label, with a median follow-up of 5.4 years, Trulicity 1.5 mg significantly reduced the risk of a first occurrence of cardiovascular death, non-fatal heart attack or non-fatal stroke compared with placebo. The hazard ratio, a comparison of risk between groups, was 0.88, with a confidence interval (the likely range) of 0.79 to 0.99.
Does Trulicity 1.5 mg cause more nausea than 0.75 mg?
In the label's pooled placebo-controlled trials, nausea was reported by 21.1% of adults on 1.5 mg and 12.4% on 0.75 mg, against 5.3% on placebo. Vomiting was reported by 12.7% on 1.5 mg and diarrhea by 12.6%. Gastrointestinal (stomach and gut) reactions led 3.5% of people on 1.5 mg to stop treatment.
Sources (8)
- 1.FDA label (DailyMed): Trulicity prescribing information, section 14.3
“At the 26-week placebo-controlled time point, the HbA1c change was 0.1%, -1.0%, -1.2%, and -0.6% for placebo, TRULICITY 0.75 mg, TRULICITY 1.5 mg, and sitagliptin, respectively.”
- 2.FDA label (DailyMed): Trulicity prescribing information, section 14.3
“At 26 weeks, there was a mean weight reduction of 1.4 kg, 2.7 kg, 3.0 kg, and 1.4 kg for placebo, TRULICITY 0.75 mg, TRULICITY 1.5 mg, and sitagliptin, respectively.”
- 3.FDA label (DailyMed): Trulicity prescribing information, section 14.5
“TRULICITY significantly reduced the risk of first occurrence of primary composite endpoint of CV death, non-fatal MI, or non-fatal stroke (HR: 0.88, 95% CI 0.79, 0.99).”
- 4.FDA label (DailyMed): Trulicity prescribing information, section 6.1
“In a 78-week adult clinical trial, hypoglycemia (glucose level <54 mg/dL) occurred in 20% and 21% of patients when TRULICITY 0.75 mg and 1.5 mg, respectively, were co-administered with a sulfonylurea.”
- 5.FDA label (DailyMed): Trulicity prescribing information, section 8.4
“The safety and effectiveness of TRULICITY have not been established in pediatric patients less than 10 years of age.”
- 6.
- 7.
- 8.
